A double-blind, placebo-controlled trial of intravenous iron dextran therapy in patients with ESRD and restless legs syndrome
To access this article, please choose from the options below
PII: S0272-6386(04)00009-5
doi:10.1053/j.ajkd.2003.11.021
© 2004 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
